Ten years doesn't sound like a long time. In the world of investing, it can seem like eons. Some reports show investors hold the average stock just 5-1/2 months. For a trader focusing on the stock price, that's a lot of red or green days that aren't very meaningful to the business. For an investor focusing on the business, it might only be long enough to hear one quarterly update from management.
To keep from getting whiplash, investors in Twist Bioscience (NASDAQ: TWST) and Pacific Biosciences of California (NASDAQ: PACB) will need to be focused on the long-term opportunity for synthetic DNA and long-read genome sequencing, respectively. Each company has a unique position in the life science industry, but short-term volatility could shake the confidence of anyone worried about the stock price over the next year or two. That's why anyone adding these stocks to a portfolio should plan to own them for a decade or more.
Image source: Getty Images.
For further details see:
2 Top Biotech Picks to Buy and Hold for the Next 10 Years